Skip to main content

Table 2 Clinical characteristics of the outbreak cases and antimicrobial susceptibility profiles of Providencia rettgeri isolates

From: Emergence of multidrug-resistant Providencia rettgeri isolates co-producing NDM-1 carbapenemase and PER-1 extended-spectrum β-lactamase causing a first outbreak in Korea

Patient ID

P1

P2

P3

P4

P5

P6

P7

P8

Isolate no.

KN756

KN762

KN764

KN774

KN779

KN784

KN803

KN804

Sex/age (year)

M/63

M/50

M/52

M/66

F/75

M/81

F/40

M/53

Diagnosis

Brain hemorrhage

Deep neck infection

Central nervous system infection

Bladder cancer

Pneumonia

Pneumonia

Brain hemorrhage

Brain hemorrhage

Comorbidities

Diabetes mellitus

Cerebral infarction

Diabetes mellitus

Outcome

Survival

Survival

Survival

Survival

Death

Survival

Survival

Survival

Hospital admission date

18-Dec-15

05-Apr-16

28-Apr-16

01-Jul-16

28-Jul-16

14-Aug-16

16-Dec-16

19-Dec-16

P. rettgeri collection date

11-Jan-16

09-May-16

19-May-16

08-Aug-16

19-Aug-16

22-Aug-16

30-Dec-16

05-Jan-17

Antimicrobial agents used before P. rettgeri isolation (days)

Colistin (13), piperacillin-tazobactam (8), teicoplanin (11)

Colistin (21), metronidazole (10), piperacillin-tazobactam (10), ampicillin-sulbactam (3), teicoplanin (20), netilmicin (5), levofloxacin (9)

Colistin (13), piperacillin-tazobactam (3), vancomycin (8), teicoplanin (13), meropenem (7)

Ceftriaxone (6), tigecycline (4), doripenem (7), piperacillin-tazobactam (18), flomoxef (3), teicoplanin (5)

Metronidazole (10), moxifloxacin (6), piperacillin-tazobactam (2), teicoplanin (2)

Piperacillin-tazobactam (5), ampicillin-sulbactam (3)

Ceftriaxone (3)

Ceftriaxone (8)

MIC (μg/mL)

 Cefotetan

> 256

> 256

> 256

> 256

> 256

> 256

> 256

> 256

 Cefotaxime

> 32

> 32

> 32

> 32

> 32

> 32

> 32

> 32

 Ceftazidime

> 256

> 256

> 256

> 256

> 256

> 256

> 256

> 256

 Cefepime

> 256

> 256

> 256

> 256

> 256

> 256

> 256

> 256

 Aztreonam

> 256

> 256

> 256

> 256

> 256

> 256

> 256

> 256

 Imipenem

0.5

0.5

2

4

0.5

1

0.5

0.5

 Meropenem

> 32

> 32

> 32

> 32

> 32

> 32

> 32

> 32

 Ertapenem

> 32

> 32

> 32

> 32

> 32

> 32

> 32

> 32

 Ciprofloxacin

> 32

> 32

> 32

> 32

> 32

> 32

> 32

> 32

 Amikacin

> 256

> 256

> 256

> 256

> 256

> 256

> 256

> 256

 Gentamicin

8

16

16

16

8

16

8

8

 Tigecycline

4

4

4

8

4

8

8

8

 Colistin

2

2

8

2

2

64

4

4

  1. MIC minimum inhibitory concentration